BNT116 is an LNP that delivers mRNA for six antigens of lung cancer (NY-ESO-1, MAGE-C2, etc.), activates antigen-specific T cells, and indirectly recruits/activates NK cells through the inflammatory microenvironment. This evidence concerns the gene MAGEC2 and lung carcinoma.